The groundbreaking success of Viagra undeniably reshaped the medication landscape, but investing in companies strongly reliant on generic versions presents a complex picture. Despite early returns were substantial, the expiration of patents and the appearance of cheaper alternatives have diminished the customer base. Thus, a thorough analysis of on